A Radiologist's Guide to the Changing Treatment Paradigm of Advanced Non–Small Cell Lung Cancer: The ASCO 2018 Molecular Testing Guidelines and Targeted Therapies

Lydia Y. Chen, Daniel A. Smith, Bhanusupriya Somarouthu, Amit Gupta, Kianoush Ansari Gilani, Nikhil H. RamaiyaAmerican 2019 · DOI

Abstract

<b>OBJECTIVE.</b> The purpose of this article is to provide an imaging-based guide of the modern genomic classifications and targeted therapies for advanced non-small cell lung cancer (NSCLC) with an emphasis on the relevance of the 2018 American Society of Clinical Oncology molecular testing guidelines for radiologists. <b>CONCLUSION.</b> Knowledge of the radiologic relevance of lung cancer driver mutations and modern targeted agents is essential for imaging interpretation of advanced NSCLC in the modern age of precision medicine.
BibTeX
@inproceedings{chen2019radiologist,
  author = {Lydia Y. Chen and Daniel A. Smith and Bhanusupriya Somarouthu and Amit Gupta and Kianoush Ansari Gilani and Nikhil H. Ramaiya},
  title = {{A Radiologist's Guide to the Changing Treatment Paradigm of Advanced Non–Small Cell Lung Cancer: The ASCO 2018 Molecular Testing Guidelines and Targeted Therapies}},
  booktitle = {American},
  year = {2019},
  doi = {10.2214/ajr.19.21135},
}

Loading related content...

Figure